Document is current
Any future updates will be listed below
-
Authors
Morohashi, Hajime
Hakamada, Kenichi
Kanno, Takahiro
Tadano, Kotaro
Kawashima, Kenji
Takahashi, Yoshiya
Ebihara, Yuma
Oki, Eiji
Hirano, Satoshi
Mori, Masaki
- License Information
-
More Information
Article History
Received: 3 June 2022
Accepted: 27 June 2023
First Online: 4 July 2023
Competing interests
: Hajime Morohashi, Kenichi Hakamada, Kotaro Tadano, Yoshiya Takahashi, Yuma Ebihara, Eiji Oki, Satoshi Hirano, and Masaki Mori have no conflicts of interest or financial ties to disclose. Takahiro Kanno has stock options of Riverfield Inc. Kenji Kawashima has founder and stock of Riverfield Inc. This work was supported by a grant from the Japan Agency for Medical Research and Development (AMED), Grant number JP21hs0122001h0002.
